Skip to main content
  • AETC National Coordinating Resource Center
  • Resources for Clinicians
  • AETC Directory
  • Download App
Home

Breadcrumb

  1. Home
  2. Antiretrovirals

Protease Inhibitors

U.S. Guidelines Links
Characteristics of Protease Inhibitors
Other Reference Links
National HIV Curriculum
Abbreviation(s)
PI
ARVs
Atazanavir
Darunavir
Nelfinavir
Tipranavir
Lopinavir/Ritonavir
Displaying 1 - 1 of 1
Interaction Color Code Clinical Bottom Line Clinical Effects Drug 1 effect Drug 2 dose Drug 2 effect Management
Darunavir
Subscribe to Protease Inhibitors
Related Co-medications
Atazanavir
Darunavir
Lopinavir/Ritonavir
Tipranavir
Nelfinavir
Atazanavir / Cobicistat
Darunavir / Cobicistat
Fosamprenavir
  • About
  • Contact Us
  • Log in

Apple Store

   Google Play

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award (grant number U1OHA28686) totaling $1,700,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.